Articles

  • 4 weeks ago | oncologynewscentral.com | Alexis Pellek |Alicia Ault |Carina Storrs |Youssef Rddad

    Practice consolidation in radiation oncology has led to fewer and larger practices, even as the total number of physicians in the specialty has steadily grown, according to a new study. The findings, published in the International Journal of Radiation Oncology, Biology, Physics, offer a clearer assessment of what had been a moving target in cancer care, experts say. “Radiation oncology is undergoing consolidation and has been since at least 2013.

  • 1 month ago | medcentral.com | Marc E. Agronin |Marcia Frellick |Avery Hurt |Alexis Pellek

    The US FDA has approved the thrombolytic drug tenecteplase (TNKase) for treatment of acute ischemic stroke. The medication was already approved for use in ST-elevation myocardial infarction (STEMI). Yasmin Aziz, MD, assistant professor of clinical neurology and rehabilitation medicine at the University of Cincinnati College of Medicine, spoke with MedCentral to offer some thoughts on how this new approval will affect clinical practice.

  • 1 month ago | medcentral.com | Alexis Pellek |Suzanne Mooney |Patrice Wendling |Marcia Frellick

    In reports published today in JAMA publications, the US Preventive Services Task Force (USPSTF) said it cannot rule for or against recommending screening for food insecurity in the primary care setting due to lack of evidence as to whether there would be more benefit than harm.

  • 1 month ago | medcentral.com | Denise Brodey |Oluoma Aneke |Alexis Pellek |Avery Hurt

    About 1.48 million bottles of the generic attention-deficit/hyperactivity disorder (ADHD) drug atomoxetine were recalled from the US market by manufacturer Glenmark Pharmaceuticals after tests found potentially harmful impurities above limits imposed by the US Food and Drug Administration (FDA), according to the FDA. Unacceptable levels of N-nitroso atomoxetine, a potential carcinogen, were found in multiple atomoxetine batches, according to the FDA.

  • Jan 10, 2025 | medcentral.com | Alexis Pellek

    There is an epidemic of loneliness in our country, defined as a distressing emotion associated with the perception that the quality and quantity of one’s social relationships are insufficient. The necessary social isolation during COVID reinforced this epidemic, and many individuals have struggled to get back to their baseline and they continue to suffer in many ways. Loneliness is dangerous. It’s well known that loneliness can be a risk for type 2 diabetes and increased risk of death.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →